Online citations, reference lists, and bibliographies.

Operative Resection Of Primary Carcinoid Neoplasms In Patients With Liver Metastases Yields Significantly Better Survival.

B. Givi, Suellen J Pommier, A. K. Thompson, B. Diggs, R. Pommier
Published 2006 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND It is unclear whether there is a benefit to resection of primary gastrointestinal carcinoid neoplasm with hepatic metastases. We investigated whether primary tumor resection in this setting led to a significant difference in outcomes. METHODS A retrospective review of patients with abdominal carcinoid neoplasms between 1995 and 2006 was performed. Data collected on patients with proven carcinoid liver metastases at initial diagnosis included whether the primary neoplasm was resected, time to progression of liver metastases, and status at last follow-up. Progression-free survival and survival were calculated by the method of Kaplan-Meier and compared by the log-rank test. RESULTS There were 84 patients, 60 of whom had their primary neoplasm resected. The resected group had a greater median progression-free survival of 56 months, compared with 25 months for the primary nonresected group (P < .001). Median survival time for the resected group was longer at 159 months, compared with 47 months for the nonresected group (P < .001). CONCLUSIONS Resection of the primary neoplasm is associated with better progression-free survival and overall survival in patients with abdominal carcinoid neoplasms. Therefore, localization and resection of the primary neoplasm should be considered, even among patients in whom the primary neoplasm is asymptomatic.
This paper references
10.1093/annonc/mdq524
[Neuroendocrine tumors].
B. Caillou (1992)
10.1016/S0140-6736(63)90951-6
THE CLASSIFICATION OF CARCINOID TUMOURS
E. D. Williams (1963)
10.1016/S0002-9610(99)80210-4
Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization.
D. Diaco (1995)
10.1177/875647939601200326
Carcinoid Heart Disease: Correlation of High Serotonin Levels with Valvular Abnormalities Detected by Cardiac Catheterization and Echocardiography
(1996)
10.1016/J.AMJSURG.2004.01.019
Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumors.
S. Toth-Fejel (2004)
Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.
O. Søreide (1992)
The classification of carcinoid tum ours.
E. Williams (1963)
10.1007/s002689900137
Progression of Metastases and Symptom Improvement from Laparotomy in Midgut Carcinoid Tumors
Charlie Makridis (1996)
[Resection of carcinoid tumors of the small intestine is still indicated in the presence of disseminated hepatic metastases].
C. Partensky (1990)
10.1016/0011-3840(89)90010-5
Carcinoid tumors and the carcinoid syndrome.
J. Feldman (1989)
10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2
An analysis of 8305 cases of carcinoid tumors
I. Modlin (1997)
10.1007/BF01658532
Surgical treatment of mid-gut carcinoid tumors
Charlie Makridis (2005)
The use of nitrogen mustard in the palliative treatment of cancer
D AWKarnofsky (1948)
10.1016/S0039-6060(97)90211-7
Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors.
Charlie Makridis (1997)
Sleisenger and Fordtran's gastrointestinal and liver disease
M. Feldman (2002)
10.1097/00000421-198602000-00020
Cancer : Principles and Practice of Oncology
V. Devita (1982)
10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma
D. Karnofsky (1948)
10.1067/MSY.2099.101430
Foregut carcinoids: a clinical and biochemical analysis.
P. Kirshbom (1999)
10.1016/J.BEEM.2004.10.003
GI carcinoid tumours: appearance of the primary and detecting metastases.
R. Gore (2005)
Carcinoid tumors and the carcinoid syndrome.
A. Barreto (1967)
10.1007/s00268-002-6630-z
Effect of Surgery on the Outcome of Midgut Carcinoid Disease with Lymph Node and Liver Metastases
P. Hellman (2002)
10.1097/01.sla.0000164073.08093.5d
Surgical Treatment of Advanced-Stage Carcinoid Tumors: Lessons Learned
J. Boudreaux (2005)
Carcinoid tumors and the carcinoid syndrome
Sapozhnikova Ma (1973)
10.1056/NEJMOA021451
Factors associated with progression of carcinoid heart disease.
J. Møller (2003)



This paper is referenced by
10.1016/B978-141604059-0.50028-X
CHAPTER 25 – Neuroendocrine Tumors of the GI Tract and Appendix
F. Graeme-Cook (2009)
10.1245/s10434-017-5899-y
Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival
Kendall J. Keck (2017)
10.1007/s00104-018-0607-4
Chirurgische Aspekte bei kleinen neuroendokrinen Dünndarmtumoren
F. Weber (2018)
10.1055/a-0604-2924
[Practice guideline neuroendocrine tumors - AWMF-Reg. 021-27].
Anja Rinke (2018)
10.4155/CLI.11.120
Advances in the management and treatment of gastroenteropancreatic neuroendocrine tumors
Eric Feliberti (2011)
10.1016/j.amjsurg.2011.12.010
Laparoscopic surgical exploration is an effective strategy for locating occult primary neuroendocrine tumors.
K. Massimino (2012)
10.1097/MPA.0000000000001391
Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary
Andrew Eugene Hendifar (2019)
10.1016/j.beem.2019.101342
Value of ileus-prophylactic surgery for metastatic neuroendocrine midgut tumours.
Frank Weber (2019)
10.1053/j.seminoncol.2012.11.007
Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
S. Wang (2013)
10.1186/s12885-019-5559-7
Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome
Sebastian Krug (2019)
10.18632/oncotarget.14156
Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases
J. Guo (2017)
10.1007/978-1-60327-997-0_6
Surgical Management of Sporadic Gastrointestinal Neuroendocrine Tumors
Glenda G. Callender (2011)
10.1007/s11154-018-9469-9
Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract
Peter E Goretzki (2018)
10.1007/s10585-014-9681-2
Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors
Scott K. Sherman (2014)
10.1016/j.bpg.2012.12.005
Surgery for GEP-NETs.
U. Knigge (2012)
10.4183/AEB.2008.447
Diagnostic and Therapeutic Approach to Small Bowel Carcinoid Tumor. Case Report
R. Pais (2008)
10.1245/s10434-015-4620-2
Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis
A. Pasquer (2015)
10.1016/j.ecl.2010.08.004
Neuroendocrine tumors: current recommendations for diagnosis and surgical management.
Saju Joseph (2011)
10.1016/J.SURG.2018.11.002
Re-evaluating resection of primary pancreatic neuroendocrine tumors.
Rodney F. Pommier (2019)
10.1038/modpathol.2012.34
Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin
Jamie Koo (2012)
10.1016/j.surg.2012.08.040
Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling.
J. Carr (2012)
10.1155/2012/782672
Surgical Treatment of Liver Metastases in Neuroendocrine Neoplasms
P. Jagannath (2012)
10.1016/j.hoc.2015.09.001
Surgical Treatment of Small Bowel Neuroendocrine Tumors.
Heather A Farley (2016)
10.1210/endrev/bnz004
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
J. Hofland (2019)
Clinical and immunohistochemical studies of small bowel carcinoid tumours
Kalle Landerholm (2011)
Neuroendokrine Neoplasien des Jejunums und Ileums
Birgit Cremer (2015)
10.1097/MD.0000000000020564
Resection for pancreatic cancer metastases contributes to survival
Hiroki Sato (2020)
10.1016/j.surg.2016.05.055
Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors
Kendall J. Keck (2017)
10.1159/000479293
Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases
M. Ronot (2017)
10.1016/j.jss.2014.05.031
Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors.
J. Maxwell (2014)
10.4172/2161-069X.1000154
Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP-Nets): A Review
Chuangqi Chen (2013)
10.4030/JJCS.40.758
A Case of Neuroendocrine Tumor at the Terminal Ileum with Multiple Liver Metastases and Sigmoid Colon Cancer
Mineto Ohta (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar